08.26.26 -- Clinical Success Of Combination Cell Therapy Hinges On Manufacturability

Uncover common GMP cleanroom compliance failures in recent FDA Warning Letters. Use these practical steps to correct operational gaps and maintain an inspection-ready facility.

Discover how hidden material transfer vulnerabilities compromise cleanroom sterility. Identify upstream storage risks and implement mechanical wiping techniques to fortify your facility.

As personalized gene therapies emerge, FDA’s plausible‑mechanism pathway offers a faster route to approval. See how this new framework could reshape development strategies and accelerate breakthrough therapies.

Protecting active powder handling requires robust containment verification. Review how human factors and complex airflow dynamics directly impact downflow booth protection levels.

Accurate sizing of large DNA fragments is crucial in long‑read sequencing. Examine how different electrophoresis methods perform with 10–20 kb smears and how to choose the most reliable approach.

Residual host cell DNA testing can create bottlenecks. Digital PCR supports more consistent quantification, simpler method deployment, and faster in-process and lot release decisions.

Evaluate your suppliers beyond delivery schedules. Align design, validation, and data integrity with GMP expectations to prevent audit findings and ensure long-term facility compliance.

As expectations for more physiologically relevant drug data rise, spheroids offer a practical path beyond 2D culture. Explore how to build reproducible 3D workflows and optimize key variables.

Quality frameworks must balance immediate compliance against long-term scale. Analyze organizational maturity and regulatory demands to select an appropriately sized system.

Rising Annex 1 demands are pushing facilities to rethink contamination control. Investigate how RABS retrofits offer a practical path to compliance, combining effective containment and faster implementation.

EU GMP Annex 1 is driving meaningful changes in how teams behave inside cleanrooms. Understand what contamination awareness really means in practice and how to build a culture where speaking up is standard.

New expectations for single-use systems require structured risk assessment and extractables testing. As compliance deadlines near, practical guidance aligns science, knowledge, regulatory readiness.

Learn how to implement a validated, broad-spectrum qPCR workflow that covers over 250 species, ensuring both regulatory compliance and accelerated speed-to-market for your clinical-grade products.

Vector redesign and regulatory hurdles can add years to development timelines. A single-partner approach helps streamline the process, secures timelines, and ensures smooth tech transfer to the clinic.

Disconnected systems can slow development by making data harder to coordinate. Learn how workflow orchestration and structured experimental design can help labs reduce friction and improve efficiency.